DNA Methylation Patterns in Bladder Cancer for Tumor Recurrence Detection
Author Information
Author(s): Negraes Priscilla D, Favaro Francine P, Camargo João Lauro V, Oliveira Maria Luiza CS, Goldberg José, Rainho Cláudia A, Salvadori Daisy MF
Primary Institution: Department of Genetics, Biosciences Institute, UNESP, Sao Paulo State University, Botucatu, Sao Paulo, Brazil
Hypothesis
Is aberrant DNA methylation of cancer-associated genes related to urinary bladder cancer recurrence?
Conclusion
CDH1 and SFN genes are not suitable biomarkers for urinary bladder cancer, while RARB and RASSF1A gene methylation may indicate early carcinogenesis.
Supporting Evidence
- CDH1 and SFN genes showed high methylation frequencies in bladder cancer.
- RARB methylation had a sensitivity of 95% and specificity of 71% for detecting cancer recurrence.
- RASSF1A gene methylation was also evaluated but showed lower specificity.
Takeaway
Scientists studied how certain genes change in bladder cancer to see if they can help find out if the cancer comes back after treatment.
Methodology
Methylation patterns of four genes were evaluated using Methylation-Specific Polymerase Chain Reaction (MSP) in fresh bladder cancer tissues and cell sediments.
Potential Biases
Potential biases in sample selection and analysis methods could affect results.
Limitations
The study may not account for all genetic variations and environmental factors affecting methylation.
Participant Demographics
49 patients with urinary bladder cancer (40 males, 9 females; median age 67.85 years).
Statistical Information
P-Value
p < 0.0001
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website